Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment

Role of Inhibin A as Biomarker for Ovarian Response to Stimulation With Gonadotropins for IVF Treatment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03607409

Enrollment

150

Registered

2018-07-31

Start date

2018-09-09

Completion date

2019-07-04

Last updated

2019-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

To evaluate the role of Inhibin A as bio marker for the number of mature oocytes, compared to Estradiol

Detailed description

Inhibin A could be an improved biomarker regarding the number of expected mature oocytes compared to estradiol.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Yes

Inclusion criteria

Patients undergoing ovarian stimulation with gonadotropins in either a GnRH-agonist or GnRH-antagonist for IVF treatment due to primary / secondary infertility.

Exclusion criteria

Patients undergoing a modified natural cycle stimulation protocol (Taymour cycle) Patients at risk for development of ovarian hyperstimulation syndrome (OHSS)

Design outcomes

Primary

Measure	Time frame	Description
Number of mature oocytes	1 year	Patients undergoing ovarian stimulation with gonadotropins

Countries

United Arab Emirates

Outcome results